Duquesne Family Office - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 208 filers reported holding NEKTAR THERAPEUTICS in Q3 2017. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.

Quarter-by-quarter ownership
Duquesne Family Office ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2021$17,960,000
+4.7%
1,000,0000.0%0.58%
+37.2%
Q2 2021$17,160,000
-14.2%
1,000,0000.0%0.42%
-3.6%
Q1 2021$20,000,000
+198.3%
1,000,000
+222.0%
0.44%
+123.9%
Q4 2019$6,704,000
-94.7%
310,579
-74.0%
0.20%
-97.2%
Q1 2018$126,694,000
+15.7%
1,192,300
-35.0%
7.00%
+26.8%
Q4 2017$109,526,000
+291.4%
1,834,000
+57.3%
5.52%
+333.7%
Q3 2017$27,986,000
+22.8%
1,166,1000.0%1.27%
+4.3%
Q2 2017$22,797,000
+45.9%
1,166,100
+75.2%
1.22%
+19.1%
Q1 2017$15,622,000
+58.9%
665,600
+16.3%
1.02%
+18.0%
Q3 2016$9,829,000
+36.4%
572,100
-12.7%
0.87%
-5.1%
Q1 2015$7,205,000
-29.0%
655,0000.0%0.92%
-7.9%
Q4 2014$10,153,000655,0001.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2017
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$82,950,0002.19%
MAVERICK CAPITAL LTD 5,678,221$94,202,0001.75%
Rhenman & Partners Asset Management AB 1,000,000$16,590,0001.48%
Goodman Financial Corp 119,198$1,977,0000.92%
Bellevue Group AG 3,632,358$60,261,0000.83%
OSTERWEIS CAPITAL MANAGEMENT INC 477,004$7,914,0000.53%
Parametrica Management Ltd 13,658$226,0000.43%
RICE HALL JAMES & ASSOCIATES, LLC 592,930$9,837,0000.40%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 67,000$1,110,0000.36%
Burleson & Company, LLC 92,836$1,617,0000.31%
View complete list of NEKTAR THERAPEUTICS shareholders